Latest filing published 14 Oct 2026 for Dr. Martens plc, €178. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Giles Wilson is a declared insider of Dr. Martens plc, with filings sourced from RNS (LSE). The record holds 47 filings, for trades running from 30 May 2024 to 12 October 2026.
Purchases make up the whole of the open-market record (5 purchases, €272k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 42 share grants. So far in 2026, the count stands at 2 purchases and no sales.
Half of the purchases are above €57k and half below. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +7.0%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 14 October 2026, the filings show a share grant worth €178 in Dr. Martens plc. The clock since the last published purchase (26 June 2026) now reads 113 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 44 declarations